BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 28597949)

  • 1. Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity.
    Ilonen J; Lempainen J; Hammais A; Laine AP; Härkönen T; Toppari J; Veijola R; Knip M;
    Pediatr Diabetes; 2018 Mar; 19(2):284-292. PubMed ID: 28597949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
    Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age at Seroconversion, HLA Genotype, and Specificity of Autoantibodies in Progression of Islet Autoimmunity in Childhood.
    Bauer W; Veijola R; Lempainen J; Kiviniemi M; Härkönen T; Toppari J; Knip M; Gyenesei A; Ilonen J
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4521-4530. PubMed ID: 31120497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR-DQ haplotypes and specificity of the initial autoantibody in islet specific autoimmunity.
    Mikk ML; Pfeiffer S; Kiviniemi M; Laine AP; Lempainen J; Härkönen T; Toppari J; Veijola R; Knip M; Ilonen J;
    Pediatr Diabetes; 2020 Nov; 21(7):1218-1226. PubMed ID: 32613719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood thyroid autoimmunity and relation to islet autoantibodies in children at risk for type 1 diabetes in the diabetes prediction in skåne (DiPiS) study.
    Jonsdottir B; Larsson C; Lundgren M; Ramelius A; Jönsson I; Larsson HE;
    Autoimmunity; 2018 Aug; 51(5):228-237. PubMed ID: 30486698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes.
    Sioofy-Khojine AB; Lehtonen J; Nurminen N; Laitinen OH; Oikarinen S; Huhtala H; Pakkanen O; Ruokoranta T; Hankaniemi MM; Toppari J; Vähä-Mäkilä M; Ilonen J; Veijola R; Knip M; Hyöty H
    Diabetologia; 2018 May; 61(5):1193-1202. PubMed ID: 29404673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study.
    Vehik K; Bonifacio E; Lernmark Å; Yu L; Williams A; Schatz D; Rewers M; She JX; Toppari J; Hagopian W; Akolkar B; Ziegler AG; Krischer JP;
    Diabetes Care; 2020 Sep; 43(9):2066-2073. PubMed ID: 32641373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of polymorphisms in non-HLA loci with autoantibodies at the diagnosis of type 1 diabetes: INS and IKZF4 associate with insulin autoantibodies.
    Lempainen J; Härkönen T; Laine A; Knip M; Ilonen J;
    Pediatr Diabetes; 2013 Nov; 14(7):490-6. PubMed ID: 23721563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children.
    Endesfelder D; Hagen M; Winkler C; Haupt F; Zillmer S; Knopff A; Bonifacio E; Ziegler AG; Zu Castell W; Achenbach P
    Diabetologia; 2016 Oct; 59(10):2172-80. PubMed ID: 27400691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes.
    Giannopoulou EZ; Winkler C; Chmiel R; Matzke C; Scholz M; Beyerlein A; Achenbach P; Bonifacio E; Ziegler AG
    Diabetologia; 2015 Oct; 58(10):2317-23. PubMed ID: 26138334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between deduced first islet specific autoantibody with sex, age at diagnosis and genetic risk factors in young children with type 1 diabetes.
    Ilonen J; Laine AP; Kiviniemi M; Härkönen T; Lempainen J; Knip M;
    Pediatr Diabetes; 2022 Sep; 23(6):693-702. PubMed ID: 35403376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population.
    Kimpimäki T; Kulmala P; Savola K; Kupila A; Korhonen S; Simell T; Ilonen J; Simell O; Knip M
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4572-9. PubMed ID: 12364437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children.
    Achenbach P; Hummel M; Thümer L; Boerschmann H; Höfelmann D; Ziegler AG
    Diabetologia; 2013 Jul; 56(7):1615-22. PubMed ID: 23539116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.
    Andersson C; Vaziri-Sani F; Delli A; Lindblad B; Carlsson A; Forsander G; Ludvigsson J; Marcus C; Samuelsson U; Ivarsson S; Lernmark A; Larsson HE;
    Pediatr Diabetes; 2013 Mar; 14(2):97-105. PubMed ID: 22957668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of slow progression to diabetes in multiple islet autoantibody-positive individuals from five longitudinal cohorts: the SNAIL study.
    Long AE; Wilson IV; Becker DJ; Libman IM; Arena VC; Wong FS; Steck AK; Rewers MJ; Yu L; Achenbach P; Casas R; Ludvigsson J; Williams AJK; Gillespie KM
    Diabetologia; 2018 Jun; 61(6):1484-1490. PubMed ID: 29532109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies.
    Strollo R; Vinci C; Napoli N; Fioriti E; Maddaloni E; Åkerman L; Casas R; Pozzilli P; Ludvigsson J; Nissim A
    Diabetes Metab Res Rev; 2019 May; 35(4):e3132. PubMed ID: 30693639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5.
    Xiang Y; Huang G; Shan Z; Pan L; Luo S; Yang L; Shi L; Li Q; Leslie RD; Zhou Z
    Acta Diabetol; 2015 Dec; 52(6):1121-7. PubMed ID: 26239144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of the Initiation of Islet Autoimmunity and Progression to Multiple Autoantibodies and Clinical Diabetes: The TEDDY Study.
    Krischer JP; Liu X; Lernmark Å; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Akolkar B;
    Diabetes Care; 2022 Oct; 45(10):2271-2281. PubMed ID: 36150053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and
    Gorus FK; Balti EV; Messaaoui A; Demeester S; Van Dalem A; Costa O; Dorchy H; Mathieu C; Van Gaal L; Keymeulen B; Pipeleers DG; Weets I;
    Diabetes Care; 2017 Aug; 40(8):1065-1072. PubMed ID: 28701370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.